BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
4 results:

  • 1. Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis.
    Moon WS; Song JS; Yu HC; Kim KM; Ahn AR
    Int J Surg Pathol; 2024 Feb; 32(1):160-164. PubMed ID: 37128663
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Secreted erbb3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis.
    Hsieh SY; He JR; Yu MC; Lee WC; Chen TC; Lo SJ; Bera R; Sung CM; Chiu CT
    J Proteome Res; 2011 Oct; 10(10):4715-24. PubMed ID: 21877752
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach.
    Neo SY; Leow CK; Vega VB; Long PM; Islam AF; Lai PB; Liu ET; Ren EC
    Hepatology; 2004 Apr; 39(4):944-53. PubMed ID: 15057898
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.